Matthew Paul Kowalsky - CHIEF OF STAFF AND CLO at Sigilon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Of Staff And Clo
Stock Symbol
SGTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Paul Kowalsky since 12/24/2023

Holdings reported by Matthew Paul Kowalsky for Sigilon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 Aug 11, 2023 Direct
Stock Option (Right to Buy) 0 $0.75 Aug 11, 2023 Direct Common Stock

Transactions reported by Matthew Paul Kowalsky for Sigilon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.